UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Annals of oncology, 2012-06, Vol.23 (6), p.1640-1645

2012

Volltextzugriff (PDF)

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of oncology, 2015-06, Vol.26 (6), p.1175-1179

2015

Volltextzugriff (PDF)

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1262-1268

1996

Volltextzugriff (PDF)

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial

Annals of internal medicine, 1999-07, Vol.131 (2), p.88

1999

Volltextzugriff (PDF)

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

Annals of oncology, 2008-03, Vol.19 (3), p.553-559

2008

Volltextzugriff (PDF)

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Annals of oncology, 2016-07, Vol.27 (7), p.1317-1323

2016

Volltextzugriff (PDF)

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

Annals of oncology, 2016-05, Vol.27 (5), p.895-901

2016

Volltextzugriff (PDF)

The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas

Blood, 1998-04, Vol.91 (8), p.2955-2960

1998

Volltextzugriff (PDF)

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1734-1741

1995

Volltextzugriff (PDF)

Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma

Blood, 1999-05, Vol.93 (9), p.3081-3087

1999

Volltextzugriff (PDF)

Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma : Update of the MDACC series

Annals of oncology, 2000, Vol.11, p.137-140

2000

Volltextzugriff (PDF)

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Annals of oncology, 2002-02, Vol.13 (2), p.318-322

2002

Volltextzugriff (PDF)

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Annals of oncology, 2001-07, Vol.12 (7), p.923-927

2001

Volltextzugriff (PDF)

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Seminars in oncology, 2000-12, Vol.27 (6), p.37-41

2000

Volltextzugriff (PDF)

Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization : A useful ancillary method for the diagnosis of mantle cell lymphoma

American journal of clinical pathology, 2000-08, Vol.114 (2), p.248-257

2000

Volltextzugriff (PDF)

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3488-3495

1997

Volltextzugriff (PDF)

Nasal-Type T/NK Lymphomas: A Clinicopathologic Study of 13 Cases

Leukemia & lymphoma, 2000-09, Vol.39 (1-2), p.139-144

2000

Volltextzugriff (PDF)

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Journal of clinical oncology, 1994-03, Vol.12 (3), p.575-579

1994

Volltextzugriff (PDF)

Primary hepatic lymphoma : favorable outcome after combination chemotherapy

Cancer, 2001-10, Vol.92 (8), p.2023-2029

2001

Volltextzugriff (PDF)

Untreated Aggressive Mantle Cell Lymphoma: Results with Intensive Chemotherapy without Stem Cell Transplant in Elderly Patients

Leukemia & lymphoma, 2000-09, Vol.39 (1-2), p.77-85

2000

Volltextzugriff (PDF)

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

Journal of clinical oncology, 1991-05, Vol.9 (5), p.762-769

1991

Volltextzugriff (PDF)

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum

International journal of radiation oncology, biology, physics, 2000-07, Vol.47 (5), p.1281-1285

2000

Volltextzugriff (PDF)

A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas

Annals of oncology, 1995-07, Vol.6 (6), p.609-612

1995

Volltextzugriff (PDF)

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma

Annals of oncology, 1998-05, Vol.9 (5), p.511-518

1998

Volltextzugriff (PDF)

Real-time 5' → 3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32)

American journal of clinical pathology, 1999-10, Vol.112 (4), p.524-530

1999

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(274)

Publikationsform

Artikel
(322)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Humans
(176)
Life Sciences & Biomedicine
(159)
Female
(137)
Male
(129)
Middle Aged
(116)
Adult
(104)
Aged
(93)
Biological And Medical Sciences
(86)
Medical Sciences
(83)
Oncology
(74)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(43)
Aged, 80 And Over
(37)
Hematology
(36)
Risk Factors
(32)
Treatment Outcome
(31)
Prospective Studies
(30)
Hematologic And Hematopoietic Diseases
(29)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Prognosis
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma

Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma : Update of the MDACC series

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization : A useful ancillary method for the diagnosis of mantle cell lymphoma

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Nasal-Type T/NK Lymphomas: A Clinicopathologic Study of 13 Cases

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Primary hepatic lymphoma : favorable outcome after combination chemotherapy

Untreated Aggressive Mantle Cell Lymphoma: Results with Intensive Chemotherapy without Stem Cell Transplant in Elderly Patients

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum

A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma

Real-time 5' → 3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32)

Suchergebnisse filtern